Literature DB >> 10495421

Distinct methylation pattern and microsatellite instability in sporadic gastric cancer.

H Suzuki1, F Itoh, M Toyota, T Kikuchi, H Kakiuchi, Y Hinoda, K Imai.   

Abstract

Aberrant 5' CpG island methylation is an alternative mechanism of gene inactivation during the development of cancer as demonstrated for several tumor-suppressor genes. Also, marked relationship of microsatellite instability (MSI) and DNA methylation has been reported in sporadic colorectal cancer, which is a result of epigenetic inactivation of hMLH1 in association of promoter hypermethylation. In the present study, we investigated the 5' CpG island hypermethylation of hMLH1, E-cadherin and p16 in 61 primary gastric cancers (GCs) by using combined bisulfite restriction analysis (COBRA) and methylation-specific PCR (MSP), and their MSI status. Of 61 GCs investigated, 5 (8.1%) tumors presented hMLH1 methylation, 16 (26.2%) and 25 (40.9%) showed E-cadherin and p16 methylation respectively, and 8 (13.1%) presented high-frequency MSI (MSI-H). Of the 8 MSI-H patients, 5 presented hMLH1 methylation, whereas no low-frequency MSI (MSI-L) and microsatellite stable (MSS) cases exhibited hMLH1 methylation (5/8 vs. 0/43, p < 0.00001). Furthermore, these patients also presented E-cadherin and p16 hypermethylation. Our data showed a significant correlation between hMLH1 methylation and MSI in GC, and suggested that a common mechanism of aberrant de novo methylation can be postulated in these cancers. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10495421     DOI: 10.1002/(sici)1097-0215(19991029)83:3<309::aid-ijc4>3.0.co;2-z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  41 in total

Review 1.  Genetic alterations in head and neck cancer: interactions among environmental carcinogens, cell cycle control, and host DNA repair.

Authors:  C Y Fan
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

Review 2.  Epigenetic gene silencing in cancer.

Authors:  B Tycko
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 3.  DNA methylation changes in gastrointestinal disease.

Authors:  Minoru Toyota; Fumio Itoh; Takefumi Kikuchi; Ayumi Satoh; Toshiro Obata; Hiromu Suzuki; Suguru Ishii; Takao Endo; Takashi Tokino; Kohzoh Imai
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

4.  MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach.

Authors:  Mitsuhiko Osaki; Toshiaki Inoue; Shigeyuki Yamaguchi; Aiko Inaba; Naruo Tokuyasu; Kuan-Teh Jeang; Mitsuo Oshimura; Hisao Ito
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

5.  Epigenetics modulates the effect of chemotherapy on gastric cancer.

Authors:  Yoshiyuki Watanabe; Fumio Itoh
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

6.  Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.

Authors:  Takayoshi Waki; Gen Tamura; Takashi Tsuchiya; Kiyoshi Sato; Satoshi Nishizuka; Teiichi Motoyama
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Diego F Calvisi; Sara Ladu; Alexis Gorden; Miriam Farina; Ju-Seog Lee; Elizabeth A Conner; Insa Schroeder; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

8.  Aberrant CpG island methylation in early-onset sporadic gastric carcinoma.

Authors:  Hee Cheol Kim; Jin Cheon Kim; Sun Ae Roh; Chang Sik Yu; Jeong Hwan Yook; Sung Tae Oh; Byung Sik Kim; Kun Choon Park; Rin Chang
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

9.  Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.

Authors:  Jennifer A Anderton; Janet C Lindsey; Meryl E Lusher; Richard J Gilbertson; Simon Bailey; David W Ellison; Steven C Clifford
Journal:  Neuro Oncol       Date:  2008-07-29       Impact factor: 12.300

10.  Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.

Authors:  Rachana Agarwal; Yuriko Mori; Yulan Cheng; Zhe Jin; Alexandru V Olaru; James P Hamilton; Stefan David; Florin M Selaru; Jian Yang; John M Abraham; Elizabeth Montgomery; Patrice J Morin; Stephen J Meltzer
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.